Pulmonary Embolism Symposium (PERT 2017)

 

Pulmonary Embolism Symposium (PERT 2017)

Panel Discussion - Q&A with the Experts from PERT 2017

By Pulmonary Embolism Symposium (PERT 2017)
By Pulmonary Embolism Symposium (PERT 2017)
10 views
October 16, 2017
Comments 0
Login to view comments. Click here to Login
Session 4: Anticoagulation
11:14

Current Regulatory Environment and Potential FDA Role in Furthering …

Pulmonary Embolism Symposium (PERT 2017)

11 views
11:46

DOACs and Other Heparin Alternatives

Pulmonary Embolism Symposium (PERT 2017)

R. Rosovsky

710 views
13:55

NOAC Reversal Agents - Our Early Experience

Pulmonary Embolism Symposium (PERT 2017)

G. Davis

635 views
10:12

Long Term Anticoagulation - How and For How Long?

Pulmonary Embolism Symposium (PERT 2017)

52 views
10:05

Panel Discussion - Q&A with the Experts from PERT 2017

Pulmonary Embolism Symposium (PERT 2017)

10 views